Mode
Text Size
Log in / Sign up

Sarcopenia and Low Grip Strength Correlate with Increased Cardiovascular Risk in Older AdultsLow Muscle Mass and Grip Strength Linked to Heart Risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Sarcopenia and low grip strength serve as significant markers for increased risk of cardiovascular events in older adults.

This meta-analysis involving approximately 2.3 million participants evaluated the link between muscle-related metrics and cardiovascular outcomes. The study specifically analyzed the impact of sarcopenia, low muscle mass, and diminished grip strength on the incidence of coronary heart disease, heart failure, and stroke.

Results indicate that sarcopenia is associated with a significantly higher risk of overall cardiovascular events. Specifically, patients with sarcopenia showed an unadjusted relative risk of 1.92. Furthermore, low muscle mass and low grip strength independently correlated with increased cardiovascular risk, with adjusted relative risks of 1.43 and 1.46, respectively.

While cardiovascular mortality showed a strong association in unadjusted analyses, the findings suggest that muscle mass and strength are critical indicators of cardiovascular health. Clinicians may consider these metrics as valuable markers for identifying patients at higher risk for cardiovascular complications.

Limitations include the use of heterogeneous criteria to define sarcopenia across the included studies. However, the large sample size provides substantial evidence that physical markers of muscle health are linked to adverse cardiovascular outcomes in older adults.

How this fits prior evidence

This meta-analysis addresses a gap in identifying non-pharmacological markers for cardiovascular risk in older adults. While previous coverage has focused on specific interventions for heart failure and stroke, such as semaglutide for HFpEF and the mothership strategy for AIS-LVO, this study provides evidence that physical markers like sarcopenia and low grip strength are associated with higher cardiovascular event risks (uRR 1.92 and 2.04, respectively).

A large analysis of approximately 2.3 million participants looked at the link between muscle health and heart health in older adults. The study specifically looked at sarcopenia, which is a condition involving low muscle mass and low grip strength.

Researchers found that people with sarcopenia had a higher risk of experiencing cardiovascular events, such as heart disease and stroke. Specifically, those with low grip strength showed a higher risk of cardiovascular events compared to those with stronger grip. The data also showed that low muscle mass was linked to a higher risk of heart issues.

It is important to note that this study shows a link between muscle loss and heart problems, but it does not prove that muscle loss causes heart disease. Because the study used different ways to define muscle loss across different groups, the results should be viewed as a starting point. These findings suggest that muscle strength may be a useful marker for identifying people who might need extra heart health support.

What this means for you:
Low muscle mass and grip strength are linked to higher risks of heart disease and stroke in older adults.

Common questions

What is sarcopenia and how does it affect heart health?

Sarcopenia is a condition characterized by low muscle mass and low grip strength. This study of 2.3 million people found that sarcopenia is associated with a higher risk of cardiovascular events, including heart disease and stroke, in older adults.

Does low grip strength increase the risk of heart problems?

Yes, the study found that low grip strength was associated with a higher risk of cardiovascular events. Specifically, the data showed an unadjusted risk ratio of 2.04 for those with low grip strength compared to those with higher strength.

Does this mean muscle loss causes heart disease?

No, the study shows a link between muscle loss and heart issues, but it does not prove that one causes the other. Muscle loss is considered a marker of risk, meaning it can help identify people who might be at higher risk for heart problems.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: The burden of cardiovascular events remains substantial with current care, highlighting the clinical importance of identifying high-risk populations. Sarcopenia, which affects 10%-27% of older adults worldwide, is modifiable but under-recognized in cardiovascular prevention because of unclear risk associations. We aimed to clarify the association between sarcopenia and cardiovascular events risk. METHODS: PubMed, Embase, and Web of Science were searched for longitudinal studies that reported on associations between sarcopenia or its related traits with cardiovascular events risk until January 2024. The primary outcome was a composite of cardiovascular events, encompassing cardiovascular diseases (such as coronary heart disease, heart failure, and stroke) and cardiovascular mortality. Data pooled using random-effects models are presented as risk ratios (RRs) and 95% confidence intervals (CIs). RESULTS: One hundred longitudinal studies (approximately 2.3 million participants) were included. Sarcopenia was associated with higher risk of cardiovascular events (unadjusted RR [uRR] = 1.92; 95% CI, 1.59-2.32; adjusted RR [aRR] = 1.63; 95% CI, 1.30-2.04) and cardiovascular diseases (uRR = 1.69; 95% CI, 1.39-2.04; aRR = 1.28; 95% CI, 1.12-1.46), whereas the association with cardiovascular mortality was significant only in unadjusted analyses (uRR = 2.28; 95% CI, 1.56-3.33; aRR = 1.61; 95% CI, 0.98-2.64). Similar associations with cardiovascular events were observed for low muscle mass (uRR = 1.61; 95% CI, 1.32-1.97; aRR = 1.43; 95% CI, 1.23-1.68) and low grip strength (uRR = 2.04; 95% CI, 1.72-2.44; aRR = 1.46; 95% CI, 1.37-1.56). CONCLUSIONS: Sarcopenia, defined using heterogeneous criteria, was associated with an increased risk of cardiovascular events later in life. These findings suggest that sarcopenia and related traits might serve as markers of elevated subsequent cardiovascular risk. PROSPERO REGISTRATION: CRD42023400266.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.